Cargando…

FRI642 The Effect Of Early Basal Insulin Administration On Diabetic Ketoacidosis (DKA) Management

Disclosure: H. Al-Marsumi: None. S.Z. Pollack: None. N. Simon: None. Background: DKA and HHS are considered serious acute complications of diabetes and constitute endocrine emergencies. Management of DKA and HHS consists of fluid, potassium replacement and weight-based adjusted rate intravenous insu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Marsumi, Hadeel, Pollack, Simcha Z, Simon, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Diabetes And Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555452/ http://dx.doi.org/10.1210/jendso/bvad114.861

Ejemplares similares

ODP628 Quality Improvement Project (QIP) On Management Of Diabetic Ketoacidosis (DKA) In Adults In A District General Hospital.
por: Haddad, Aiman, et al.
Publicado: (2022)

FRI658 Diabetic Ketoacidosis Masked By Cannabis In Type 2 Diabetes Mellitus
por: Bosques-Lorenzo, Jaymilitte, et al.
Publicado: (2023)

PSUN267 New-Onset Type 1 Diabetes (T1D) In a Child Presenting With Diabetic Ketoacidosis (DKA) and Severe Hypertriglyceridemia Without Pancreatitis
por: Vitale, Rebecca, et al.
Publicado: (2022)

THU380 A Case Of Alpelisib Induced Diabetic Ketoacidosis (Dka) In A Patient With Type 2 Diabetes Mellitus And Rechallenge With SGLT2 Inhibitor
por: Sekar, Vijaykumar, et al.
Publicado: (2023)

FRI645 A Case Of Diabetic Ketoacidosis After Initiation Of Decitabine And Venetoclax Chemotherapy
por: Maini, Rohan, et al.
Publicado: (2023)

FRI629 A Mysterious Case Of Mother's Battle With Diabetic Ketoacidosis During Pregnancy
por: Sittirat, Petchpailin D, et al.
Publicado: (2023)

ODP165 Atypical DKA? Think Cannabis!
por: Albashaireh, Arwa, et al.
Publicado: (2022)

PSUN240 A Case of Euglycemic DKA in Pregnancy
por: Grigoryan, Seda, et al.
Publicado: (2022)

FRI638 Glycemic And Cost Outcomes In Hispanic/Latino People With Type 2 Diabetes Initiating Dulaglutide Or Basal Insulin In The US
por: Hoog, Meredith, et al.
Publicado: (2023)

SUN-178 A Not So "Sweet" DKA: A Case of Euglycemic Diabetic Ketoacidosis Caused by Dapagliflozin/Liraglutide Combination
por: Sideri Gugger, Aristea, et al.
Publicado: (2019)

SAT058 Diabetes Complicated By DKA, Mucormycosis And Covid-19
por: Gordon, Ashley
Publicado: (2023)

THU376 Isotretinoin Related DKA In Type 2 Diabetes
por: Radovanovic, Natasa, et al.
Publicado: (2023)

ODP244 SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges
por: Penna, Laurianne El Musa, et al.
Publicado: (2022)

FRI631 Insulin Antibody Mediated Extremely Insulin Resistant In Pregnancy
por: Liu, Zhao, et al.
Publicado: (2023)

MON-154 Abnormal Glucose Homeostasis in Spinal Muscular Atrophy (SMA) Leading to a Transient Episode of Diabetic Ketoacidosis (DKA)
por: Hossain, Sabina, et al.
Publicado: (2019)

PSUN251 Euglycemic DKA In A Patient Undergoing Major Surgery
por: Dapas, Natalie, et al.
Publicado: (2022)

THU360 Hyperglycemic DKA In Patient On Monotherapy With SGLT-2 Inhibitor
por: Ahmed, Samihah, et al.
Publicado: (2023)

THU374 Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab
por: Iqbal, Iqra, et al.
Publicado: (2023)

FRI617 Targeting Unc119b For Insulin Sensitization
por: Mittal, Ayushi, et al.
Publicado: (2023)

THU247 Characterizing Inpatient Cases Of DKA Precipitated By SGLT2 Inhibitor Use
por: Aslamy, Arianne, et al.
Publicado: (2023)

LBODP057 Association Between DKA And Live Abscess: Results From The National Inpatient Sample
por: Muammar, Ahmad, et al.
Publicado: (2022)

THU291 Successful Reversal Of Glucose Toxicity After DKA Precipitated By SGLT2 Inhibitor
por: Abdelrahman, Houda, et al.
Publicado: (2023)

SAT-LB112 An Unusual Case of Ipilimumab/Nivolumab Induced Fulminant Diabetic Ketoacidosis (DKA) in a Non Diabetic Patient - a Case Report
por: Abdelmasih, Randa, et al.
Publicado: (2020)

Selecting Patients at Risk of Developing DKA on Gliflozins
por: Maletkovic, Jelena
Publicado: (2021)

Euglycemic DKA Associated With SGLT2 Inhibitors
por: TakallooBakhtiari, Asieh, et al.
Publicado: (2021)

FRI654 Concentrated Regular U-500 Insulin In An Automated Insulin Delivery System: A Case Report
por: Aurora, John, et al.
Publicado: (2023)

Latent Autoimmune Diabetes in an Adult Male Presenting With Diabetic Ketoacidosis (DKA)
por: Imam, Syed K, et al.
Publicado: (2023)

ODP230 Outcomes of DKA Based on Hospital Teaching Status: A National Inpatient Sample Analysis
por: Ramirez, Marcelo, et al.
Publicado: (2022)

THU379 A Case Of Hyperglycemia With Severe Anion Gap Metabolic Acidosis: HHS Vs DKA
por: Shrivastava, Mashu, et al.
Publicado: (2023)

Precipitation of Euglycemic DKA (euDKA) From the Initiation of SGLT2 Inhibitor (SGLT2i) and 0-Carb Diet Inpatient
por: Popli, Rakesh, et al.
Publicado: (2021)

THU316 Relatively Rare And Increasingly Fatal; A Case Of Euglycemic DKA In A Patient With Gestational Diabetes
por: Dimech, Christina, et al.
Publicado: (2023)

SAT036 Chlorthalidone Implicated In The Development Of DKA HHS Overlap In A Patient With Type II Diabetes Mellitus
por: Hilder, Robin T
Publicado: (2023)

MON-638 The WBC Differential in Relation to DKA Severity
por: Alamri, Bader Nasser, et al.
Publicado: (2020)

Severe Acute Kidney Injury Secondary to Rhabdomyolysis in Diabetic Ketoacidosis (DKA): A Case Report
por: AL Aldahan, Zahidah A, et al.
Publicado: (2022)

ODP217 Is Major Depressive Disorder in DKA Associated with Worse Patient Outcomes? A National Readmission Database Analysis
por: Ramirez, Marcelo, et al.
Publicado: (2022)

PSAT035 COVID-19 Infection Increases DKA and mortality- A Harbinger for Increased Acute Diabetes Emergencies in the Future?
por: Firek, Anthony, et al.
Publicado: (2022)

FRI641 Assessing Insulin Prescription Adequacy At Hospital Discharge And Its Association With Characteristics Of Diabetic Patients
por: Akcan, Tugce, et al.
Publicado: (2023)

ODP212 Inpatient Euglycemic DKA due to SGLT2 Inhibitors – Lessons From a Case Series and Strategies to Decrease Incidence
por: Burkhardt, Daniel, et al.
Publicado: (2022)

THU387 Euglycemic Diabetic Ketoacidosis And SGLT-2 Inhibitor Use
por: Abrahimi, Nora, et al.
Publicado: (2023)

FRI603 Treatment Of Severe Refractory Hypoglycemia Due To Malignant Insulinoma With A Novel Anti-insulin Receptor Antibody
por: Osataphan, Soravis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_04qscerlejktguhkk8ev2h0c4c